Loading clinical trials...
Loading clinical trials...
A Phase 4 Open-label, Non-randomized Study Evaluating the Pharmacokinetics and Safety of TRULANCE® (Plecanatide) in Breast Milk of Lactating Women Treated With TRULANCE
Conditions
Interventions
Plecanatide
Locations
3
United States
Synergy Research Center 002
North Hollywood, California, United States
Syergy Research Center 003
Tamarac, Florida, United States
Synergy Research Center 001
Raleigh, North Carolina, United States
Start Date
June 21, 2018
Primary Completion Date
December 14, 2018
Completion Date
December 14, 2018
Last Updated
November 22, 2019
NCT04838522
NCT06736912
NCT03879239
NCT02819297
NCT03097861
NCT01982240
Lead Sponsor
Bausch Health Americas, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions